Comparison of Oral and Intravenous Ibuprofen for PDA Treatment in Premature Infants
Learn more about:
Related Clinical Trial
Liver Regional Oxygen Saturation in Preterm Patent Ductus Arteriosus
Echocardiography-guided Percutaneous Patent Ductus Arteriosus Closure
PMCF Study to Evaluate Efficacy, Safety of the Occlutech PDA Occluder in Patients With Patent Ductus Arteriosus Defects
Optimal Dose of Surfactant for Preterm Infants With Respiratory Distress Syndrome
Effect of PDA Closure on the Left Ventricular Remodeling
Clinical Profile of Neonates Having Patent Ductus Arteriosus
Prophylactic Treatment of the Ductus Arteriosus in Preterm Infants by Acetaminophen
Aminoglycosides and Duct
Radiation-Free Heart Catheterization Using MRI
Hemodynamic Responses to Cardio-respiratory Events in Preterm Infants
Paracetamol (Acetaminophen) for Closure of PDA in Preterm Infants
The Pharmacology and Hemodynamics of Dexmedetomidine in Children With Congenital Heart Disease
Impact of Maternal-infant Therapeutics on Safety, Mortality, and Disability
The Preterm Infants’ Paracetamol Study
Fenoldopam to Prevent Renal Dysfunction in Indomethacin Treated Preterm Infants
Curosurf and Survanta Treatment(CAST)of RDS in Very Premature Infants
Evaluation of the Brain and Renal Regional Oxygenation Using NIRS in Preterm Infants
Feasibility, Efficacy and Safety of IBS ® for Implantaiton in the PDA in Duct-dependent Cyanotic CHD
Hyperion™ International Registry Trial
NIRS in PDA VLBW Infants
Amplatzer Piccolo Occluder Japan Post-marketing Database Surveillance
Comparison of Oral and Intravenous Ibuprofen for PDA Treatment in Premature Infants
The Impact of Platelet Functions on Spontaneous Ductal Closure in Preterm Infants
Lifetech CeraFlex™ Post-Market Surveillance Study
Treatment of a PDA With Acetaminophen in Preterm Neonates: Exploring Various Indications
Nit-Occlud PDA Post-Approval Study
Ibuprofen and Renal Function in Premature Infants
A New Device for Measuring of Lung Photoplethysmography and Pulmonic Arterial Saturation
Canadian National PDA Treatment Study
Long Term Results of 450 Percutaneous Closures of PDA in a Single Center
Efficacy and Safety of Oral Versus Intravenous Ibuprofen for PDA Treatment in ELBW Infants
AMPLATZER Duct Occluder II Additional Sizes
A NEW SCORING SYSTEM FOR PREDICTION OF PDA
Clinical Trial to Evaluate Two Guidelines for the Administration of Ibuprofen in the Treatment of Persistent Ductus Arteriosus Eco-guided: Impact in the Intestinal Prognosis
Feeding During Ibuprofen or Indomethacin Treatment of Preterm Infants
The Efficacy of Implementing a Treatment Algorithm in Managing Patent Ductus Arteriosus (PDA) in the Extremely Low Birth Weight Neonatal Population.
Safety and Efficacy of Ibuprofen in Term Newborns With Patent Ductus Arteriosus (PDA)
Ibuprofen vs. Continuous Indomethacin in the Treatment of PDA
Addition of Acetaminophen in Standard PDA Management
Second Course of Therapy for Resistant Patent Ductus Arteriosus (PDA)
Safety/Efficacy Study of Optimizing Ibuprofen Dosing to Achieve Higher PDA Closure Rates
Paracetamol Versus Ibuprofen for PDA Closure
Population Pharmacokinetics and Dosage Individualization of Paracetamol and Ibuprofen in Children With PDA
Brain, Gut and Kidney Blood Flow During Medical Closure of PDA
Timing for the Medical Treatment of Patent Ductus Arteriosus in Preterm Infants
Early Treatment Versus Expectative Management of PDA in Preterm Infants
International Experience in Timing And Choices for Ductal Closure in Patent Ductus Arteriosus:INTERPDA Trial
Comparative Study of Efficacy and Safety of Oral Ibuprofen and Intravenous Ibuprofen in Closure of Patent Ductus Arteriosus in Very Low Birth Weight Infants
Do Elevated BNP Levels Predict Hemodynamically Significant PDAs
The Use of B-type Natriuretic Peptide (BNP) to Predict Closure of a Patent Ductus Arteriosus (PDA) in Premature Infants
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
Serum Level Measurement of Oral Paracetamol and Oral Ibuprofen for Patent Ductus Arteriosus Treatment in Preterm Infants
The Role of Fetal Ductus Arteriosus in Predicting Spontaneous Labour at Term
AMPLATZER Duct Occluder II Clinical Study
The Role of Fetal Ductus Arteriosus in Predicting Spontaneous Preterm Birth
Paracetamol and Patent Ductus Arteriosus (PDA)
Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes
Oral Paracetamol Versus Oral Ibuprofen in Management of Patent Ductus Arteriosus in Preterm Infants: A Randomised Controlled Trial
Early Versus Late Use of Ibuprofen for Patent Ductus Arteriosus (PDA) Closure
Pocket Echocardiography System (PES) for Detection of PDA in Neonates
Comparison of 2 Different Indomethacin Dosing Protocols to Treat Infants Delivered at
Near Infrared Spectroscopy to Determine Patent Ductus Arteriosus Closure
Treating the Resistant Patent Ductus Arteriosus (PDA)
Echocardiographically Guided Versus Standard Ibuprofen Treatment for Patent Ductus Arteriosus
IV Acetaminophen and Patent Ductus Arteriosus
Closure Of Patent Ductus Arteriosus With the AMPLATZER Duct Occluder the AMPLATZER® Duct Occluder
Closure of Patent Ductus Arteriosus With Indomethacin or Ibuprofen in Extreme Low Birth Weight Infants
Platelet Transfusion for Treatment of Patent Ductus Arteriosus in Thrombocytopenic Preterm Neonates
Nitric Oxide, Endothelin-1, and the Patency of Ductus Arteriosus in Preterm Infants
Early Ibuprofen Treatment of Patent Ductus Arteriosus (PDA) in Premature Infants (TRIOCAPI)
Influence of Treatment for Patent Ductus Arteriosus on Cerebral Oxygenation in Preterm Infants
An Escalating Dose Indomethacin for the Treatment of Persistent Patent Ductus Arteriosus (PDA) In Preterm Infants
Patent Ductus Arteriosus and Splanchnic Oxygenation at First Feed
Preliminary Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low-weight Infants
Non-Invasive Detection of Tissue Oxygen Deprivation in Premature Infants With Patent Ductus Arteriosus.
Safety and Effectiveness Study With a New PDA Occluder for Closure of Patent Ductus Arteriosus